The Radioimmunoassay Market is expanding as the global burden of chronic diseases increases demand for highly sensitive diagnostic testing. According to a recent report by Wise Guys Report, the market was valued at USD 0.84 billion in 2025 and is projected to reach USD 1.49 billion by 2035, registering a CAGR of 5.9% during 2026–2035. Radioimmunoassay remains valuable for measuring specific hormones, biomarkers, and other low-concentration substances. Market Growth is being supported by increasing cancer prevalence, endocrine disorders, laboratory modernization, and pharmaceutical research. Hospitals, diagnostic laboratories, and research institutions continue using radioimmunoassay technologies where high analytical sensitivity is required.

The future of the Radioimmunoassay Market will be influenced by analyzer automation, digital quality-control systems, advanced reagents, and improved laboratory connectivity. Market Trends indicate that emerging economies are also expanding diagnostic infrastructure, creating opportunities for assay manufacturers. Market Analysis suggests that companies developing efficient platforms and validated assay kits can benefit from recurring diagnostic demand. North America currently leads the market, while Asia-Pacific is projected to record faster growth.